HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martha Arellano Selected Research

SAR103168

2/2015Phase I trial of SAR103168, a novel multi-kinase inhibitor, in patients with refractory/relapsed acute leukemia or high-risk myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martha Arellano Research Topics

Disease

12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 02/2010
10Neoplasms (Cancer)
01/2021 - 11/2004
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2020 - 01/2010
4Leukemia
02/2015 - 01/2013
4Mouth Neoplasms (Oral Cancer)
04/2012 - 01/2008
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2018 - 02/2015
3Hematologic Neoplasms (Hematological Malignancy)
08/2015 - 08/2010
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 10/2008
2Exanthema (Rash)
12/2017 - 02/2010
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2014 - 01/2013
2Lymphoma (Lymphomas)
12/2013 - 10/2006
2Hodgkin Disease (Hodgkin's Disease)
12/2013 - 10/2006
2Thrombocytopenia (Thrombopenia)
11/2012 - 11/2012
2Febrile Neutropenia
11/2012 - 02/2010
2Squamous Cell Carcinoma of Head and Neck
04/2012 - 10/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2012 - 10/2006
1Inflammation (Inflammations)
10/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2018
1Bronchiolitis Obliterans Syndrome
01/2018
1Infections
01/2018
1Sepsis (Septicemia)
01/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
11/2013
1Hemorrhage
11/2013
1Pneumonia (Pneumonitis)
11/2012
1Neutropenia
11/2012
1Myeloid Leukemia (Leukemia, Myelocytic)
07/2012

Drug/Important Bio-Agent (IBA)

5Tyrosine Kinase InhibitorsIBA
05/2020 - 03/2011
5Cytarabine (Cytosar-U)FDA LinkGeneric
11/2018 - 10/2006
5Proteins (Proteins, Gene)FDA Link
01/2018 - 10/2008
5Phosphotransferases (Kinase)IBA
08/2015 - 03/2011
4Azacitidine (5 Azacytidine)FDA Link
01/2021 - 08/2015
4Imatinib Mesylate (Gleevec)FDA Link
12/2017 - 01/2010
3venetoclaxIBA
01/2021 - 01/2018
3Dasatinib (BMS 354825)FDA Link
12/2017 - 01/2010
3Biomarkers (Surrogate Marker)IBA
04/2012 - 10/2008
2DecitabineFDA Link
01/2021 - 01/2019
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2021 - 01/2019
2nilotinibFDA Link
12/2017 - 03/2011
2amsonic acid (DAS)IBA
12/2017 - 01/2010
2Tyrosine (L-Tyrosine)FDA Link
09/2014 - 08/2014
2Epidermal Growth Factor (EGF)IBA
09/2014 - 02/2014
2Vinorelbine (Navelbine)FDA LinkGeneric
12/2013 - 10/2006
2Paclitaxel (Taxol)FDA LinkGeneric
12/2013 - 10/2006
2Cisplatin (Platino)FDA LinkGeneric
12/2013 - 10/2006
2Etoposide (VP 16)FDA LinkGeneric
12/2013 - 10/2006
2Clofarabine (Clolar)FDA Link
03/2012 - 02/2010
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2008 - 11/2004
2Vaccine AdjuvantsIBA
03/2008 - 11/2004
2CytokinesIBA
03/2008 - 11/2004
2VaccinesIBA
03/2008 - 11/2004
1alpha-hydroxyglutarateIBA
01/2021
1ChemokinesIBA
10/2020
1Histone Deacetylase InhibitorsIBA
01/2019
1SB939 compoundIBA
01/2019
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2019
1glasdegibIBA
11/2018
1Daunorubicin (Cerubidine)FDA LinkGeneric
11/2018
1SteroidsIBA
01/2018
1ruxolitinibIBA
01/2018
1Janus KinasesIBA
01/2018
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2015
1ilorasertibIBA
08/2015
1Aurora KinasesIBA
08/2015
1SAR103168IBA
02/2015
1Monoclonal AntibodiesIBA
08/2014
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
08/2014
1Glucose (Dextrose)FDA LinkGeneric
08/2014
1Oxidoreductases (Dehydrogenase)IBA
08/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2014
1Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
08/2014
1Pyruvate Dehydrogenase (Lipoamide)-Phosphatase (Pyruvate Dehydrogenase Phosphatase)IBA
08/2014
1Serine (L-Serine)FDA Link
08/2014
1Pyruvic Acid (Pyruvate)IBA
08/2014
15'-oleoyl cytarabineIBA
06/2014
1Sirtuin 3IBA
02/2014
1AcetyltransferasesIBA
02/2014
1Lysine (L-Lysine)FDA Link
02/2014
1Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric
11/2013
1Antifibrinolytic Agents (Antifibrinolytics)IBA
11/2013
1Ikaros Transcription FactorIBA
01/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1Heparin (Liquaemin)FDA LinkGeneric
11/2012
1ImmunosorbentsIBA
11/2012
1AntibodiesIBA
11/2012
1Indicators and Reagents (Reagents)IBA
11/2012
1EnzymesIBA
11/2012
1antineoplaston A10 (A 10)IBA
11/2012
1filanesibIBA
07/2012
1KinesinsIBA
07/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2012
1Dexamethasone (Maxidex)FDA LinkGeneric
04/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2012

Therapy/Procedure

4Therapeutics
01/2019 - 03/2008
2Salvage Therapy
12/2013 - 10/2006
1Precision Medicine
12/2020
1Aftercare (After-Treatment)
05/2020
1Drug Tapering
12/2017
1Platelet Transfusion (Blood Platelet Transfusions)
11/2013
1Induction Chemotherapy
11/2012